3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is growing attracting clinical scrutiny due to initial data suggesting different pharmacological actions. Preliminary analyses indicate that https://www.pinterest.com/pin/1140888518124046392/